Valuation: DiaSorin S.p.A.

Market Cap 3.98B 4.58B 3.72B 3.41B 6.44B 437B 6.55B 43.85B 17.17B 218B 17.22B 16.84B 719B P/E 2026 *
21.6x
P/E 2027 * 19.1x
Enterprise Value 4.68B 5.39B 4.37B 4.01B 7.56B 513B 7.7B 51.53B 20.18B 256B 20.23B 19.78B 844B EV / Sales 2026 *
3.79x
EV / Sales 2027 * 3.45x
Free-Float
37.17%
Yield 2026 *
1.74%
Yield 2027 * 1.83%
1 day-0.88%
1 week+5.49%
Current month+3.67%
1 month+6.19%
3 months+25.21%
6 months+0.89%
Current year+8.57%
1 week 68.74
Extreme 68.74
76.46
1 month 63
Extreme 63
76.46
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
92.32
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 26/03/2007
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 28/04/2016
Director/Board Member 63 26/03/2007
Chairman 57 29/04/2022
Date Insider Type Main position Quantity % Market Cap.
28/01/26 Buy

Chief Executive Officer

7,500 0.0134%
08/01/26 Buy

Director

700 0.0013%
08/01/26 Buy

Director

1,000 0.0018%
Change 5-day change 1-year change 3-year change Capi.($)
-0.88%+5.49%-12.35%-21.74% 4.58B
+0.78%+11.05%+260.93%+321.72% 21.31B
+0.48%-3.14%-42.15%-23.22% 9.78B
-0.04%-1.43%+41.58%+33.66% 6.59B
-1.27%-1.07%+240.24%-16.94% 5.97B
-2.21%-0.17%-13.57%-17.52% 5.58B
-0.67%+3.01%-45.54% - 4.61B
+4.10%-7.04%+71.82%+88.46% 4.01B
-1.79%+5.17%-16.16%-36.46% 2.89B
-6.92%-14.77%-54.30%+144.09% 1.38B
Average -0.79%+1.48%+43.05%+52.45% 6.67B
Weighted average by Cap. -0.01%+3.75%+100.14%+112.76%

Financials

2026 *2027 *
Net sales 1.23B 1.42B 1.15B 1.06B 1.99B 135B 2.03B 13.59B 5.32B 67.51B 5.34B 5.22B 223B 1.31B 1.51B 1.22B 1.12B 2.12B 144B 2.15B 14.43B 5.65B 71.68B 5.66B 5.54B 236B
Net income 181M 208M 169M 155M 292M 19.8B 297M 1.99B 778M 9.87B 780M 763M 32.57B 205M 236M 192M 176M 332M 22.54B 338M 2.26B 886M 11.24B 888M 868M 37.07B
Net Debt 697M 802M 651M 598M 1.13B 76.47B 1.15B 7.68B 3.01B 38.14B 3.01B 2.95B 126B 539M 620M 503M 462M 871M 59.09B 886M 5.93B 2.32B 29.47B 2.33B 2.28B 97.2B
Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2025, the group had 9 production sites located in Italy, the United States (4), Canada, Germany, the United Kingdom and Chine. Net sales are distributed geographically as follows: Italy (15.2%), Europe (24.9%), North America (51.8%), and other (8.1%).
Employees
3,242
Date Price Change Volume
04/08/26 74.50 -0.88% 191,765
03/08/26 €75.16 +4.59% 567,451
31/07/26 €71.86 +4.21% 747,077
30/07/26 €68.96 -2.68% 166,617
29/07/26 €70.86 +0.34% 279,951
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
75.16EUR
Average target price
72.45EUR
Spread / Average Target
-3.61%

Quarterly revenue - Rate of surprise